Reproducibility crisis: Blame it on the antibodies
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These serum cTnI enrichment results illustrate the major benefits of functionalized NPs compared to current antibody-based approaches: (1) NPs are capable of reproducibly and effectively enriching cTnI (Supplementary Fig. 23) across all tested serum samples without the use of antibody, thus overcoming the intrinsic antibody-related limitations (vide supra)14,15,51–53.”
From Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum (2020) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, these NPs can serve as replacements to conventional immuno-based techniques to overcome the antibody-related limitations in cTnI immunoassays and potentially address the current reproducibility crisis caused by antibodies in general14–16,51,53.”
From Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum (2020) · cites this paper as [14]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Yet a recent survey found that 70% of scientists have tried and failed to reproduce results from a published experiment.1”
From Reproducibility of Quantitative Systems Pharmacology Models: Current Challenges and Future Opportunities (2019) · cites this paper as [1]
Experimental — accuracy not yet measuredIn the citing paper
“However, antibodies possess many inherent limitations: batch-to-batch variation, high cost of production, poor chemical stability, and lack of proteoform-specific epitope recognition that collectively contribute to reproducibility issues [62–64].”
From Top-down proteomics: challenges, innovations, and applications in basic and clinical research (2020) · cites this paper as [63]
In the citing paper
“However, antibody-based platforms suffer from significant limitations including the batch-to-batch variability, high cost of the antibody production, and relatively low chemical stability14,15.”
From Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum (2020) · cites this paper as [14]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Raise standards for preclinical cancer research
Begley, C. G., & Ellis, L. M. (2012) · Nature · doi:10.1038/483531a · Cited by 2,979
A Genecentric Human Protein Atlas for Expression Profiles Based on Antibodies
Berglund, L., Björling, E., Oksvold, P., Fagerberg, L., Asplund, A., Al-Khalili Szigyarto, C., Persson, A., Ottosson, J., Wernérus, H., Nilsson, P., et al. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r800013-mcp200 · Cited by 672
Reproducibility: Standardize antibodies used in research
Bradbury, A., & Plückthun, A. (2015) · Nature · doi:10.1038/518027a · Cited by 647
Bordeaux, J., Welsh, A. W., Agarwal, S., Killiam, E., Baquero, M. T., Hanna, J. A., Anagnostou, V. K., & Rimm, D. L. (2010) · BioTechniques · doi:10.2144/000113382 · Cited by 589
An assessment of histone-modification antibody quality
Egelhofer, T. A., Minoda, A., Klugman, S., Lee, K., Kolasinska-Zwierz, P., Alekseyenko, A. A., Cheung, M.-S., Day, D. S., Gadel, S., Gorchakov, A. A., et al. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1972 · Cited by 428
How reliable are G-protein-coupled receptor antibodies?
Michel, M. C., Wieland, T., & Tsujimoto, G. (2009) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-009-0395-y · Cited by 306
Prassas, I., & Diamandis, E. P. (2014) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2013-1078 · Cited by 31
Cited by
A subcellular map of the human proteome
Thul, P. J., Åkesson, L., Wiking, M., Mahdessian, D., Geladaki, A., Ait Blal, H., Alm, T., Asplund, A., Björk, L., Breckels, L. M., et al. (2017) · Science · doi:10.1126/science.aal3321 · Cited by 2,813
The Encyclopedia of DNA elements (ENCODE): data portal update
Davis, C. A., Hitz, B. C., Sloan, C. A., Chan, E. T., Davidson, J. M., Gabdank, I., Hilton, J. A., Jain, K., Baymuradov, U. K., Narayanan, A. K., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1081 · Cited by 1,717
Alexander, S. P. H., Roberts, R. E., Broughton, B. R. S., Sobey, C. G., George, C. H., Stanford, S. C., Cirino, G., Docherty, J. R., Giembycz, M. A., Hoyer, D., et al. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14112 · Cited by 891
“Undeniably, as a result of unintentional mistakes (often related to lack of antibody specificity; Baker, 2015), but, in some cases, deliberate alterations and questionable interpretations of results, the use of these two methods has led to many high profile retractions.”
ResultThe Cellosaurus, a Cell-Line Knowledge Resource
Bairoch, A. (2018) · Journal of Biomolecular Techniques JBT · doi:10.7171/jbt.18-2902-002 · Cited by 807
Molecular Imprinting: Green Perspectives and Strategies
Arabi, M., Ostovan, A., Li, J., Wang, X., Zhang, Z., Choo, J., & Chen, L. (2021) · Advanced Materials · doi:10.1002/adma.202100543 · Cited by 780
Limitations of Animal Studies for Predicting Toxicity in Clinical Trials
Van Norman, G. A. (2019) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2019.10.008 · Cited by 732
Preferred Reporting Items for Systematic Reviews and Meta-Analyses
Vrabel, M. (2015) · Oncology Nursing Forum · doi:10.1188/15.onf.552-554 · Cited by 669
Spatial proteomics: a powerful discovery tool for cell biology
Lundberg, E., & Borner, G. H. H. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0094-y · Cited by 591
Genetics meets proteomics: perspectives for large population-based studies
Suhre, K., McCarthy, M. I., & Schwenk, J. M. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-020-0268-2 · Cited by 478
Greenificated Molecularly Imprinted Materials for Advanced Applications
Ostovan, A., Arabi, M., Wang, Y., Li, J., Li, B., Wang, X., & Chen, L. (2022) · Advanced Materials · doi:10.1002/adma.202203154 · Cited by 442
Arabi, M., Ostovan, A., Zhang, Z., Wang, Y., Mei, R., Fu, L., Wang, X., Ma, J., & Chen, L. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112825 · Cited by 404
BCPT 2023 policy for experimental and clinical studies
Tveden‐Nyborg, P., Bergmann, T. K., Jessen, N., Simonsen, U., & Lykkesfeldt, J. (2023) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13944 · Cited by 322
“The disclosure of an apparent and low degree of reproducibility has fuelled investigations of causal factors, ranging from behavioural preferences in decision-making/‘human nature’and conviction bias to experimental constituents.(1) The increased awareness has identified several aspects in data collection, analysis an…”
BackgroundBCPT policy for experimental and clinical studies
Tveden‐Nyborg, P., Bergmann, T. K., Jessen, N., Simonsen, U., & Lykkesfeldt, J. (2021) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13492 · Cited by 316
Switchable Fluorophores for Single-Molecule Localization Microscopy
Li, H., & Vaughan, J. C. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00767 · Cited by 319
Durable and controlled depletion of neutrophils in mice
Boivin, G., Faget, J., Ancey, P.-B., Gkasti, A., Mussard, J., Engblom, C., Pfirschke, C., Contat, C., Pascual, J., Vazquez, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16596-9 · Cited by 300
Nonspecific Binding—Fundamental Concepts and Consequences for Biosensing Applications
Frutiger, A., Tanno, A., Hwu, S., Tiefenauer, R. F., Vörös, J., & Nakatsuka, N. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00044 · Cited by 278
Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?
Chappell, M. C. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00618.2015 · Cited by 280
“Issues with antibody specificity are certainly not limited to the RAS components and present a major concern regarding the unreliability of antibodies against their intended targets (13).”
BackgroundBasic & Clinical Pharmacology & Toxicology Policy for Experimental and Clinical studies
Tveden‐Nyborg, P., Bergmann, T. K., & Lykkesfeldt, J. (2018) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13059 · Cited by 271
De novo design of high-affinity binders of bioactive helical peptides
Vázquez Torres, S., Leung, P. J. Y., Venkatesh, P., Lutz, I. D., Hink, F., Huynh, H.-H., Becker, J., Yeh, A. H.-W., Juergens, D., Bennett, N. R., et al. (2024) · Nature · doi:10.1038/s41586-023-06953-1 · Cited by 239
“Antibodies have served as the industry standard for affinity reagents for many years, but their use is often hampered by variable specificity and stability 10,11 .”
SON and SRRM2 are essential for nuclear speckle formation
Ilik, İ. A., Malszycki, M., Lübke, A. K., Schade, C., Meierhofer, D., & Aktaş, T. (2020) · eLife · doi:10.7554/elife.60579 · Cited by 267
“One of the primary culprits in the so-called ‘reproducibility crisis’ in natural sciences is considered to be mischaracterized antibodies (Baker, 2015), which led to initiatives to validate them appropriately (Uhlen et al., 2016), and large consortia such as ENCODE (Davis et al., 2018) publishes…”
BackgroundGastrointestinal mucosal barrier function and diseases
Oshima, T., & Miwa, H. (2016) · Journal of Gastroenterology · doi:10.1007/s00535-016-1207-z · Cited by 247
Insufficient antibody validation challenges oestrogen receptor beta research
Andersson, S., Sundberg, M., Pristovsek, N., Ibrahim, A., Jonsson, P., Katona, B., Clausson, C.-M., Zieba, A., Ramström, M., Söderberg, O., et al. (2017) · Nature Communications · doi:10.1038/ncomms15840 · Cited by 247
“This is increasingly recognized as a factor contributing to poor reproducibility of biomedical studies 27,28 .”
The Human Proteoform Project: Defining the human proteome
Smith, L. M., Agar, J. N., Chamot-Rooke, J., Danis, P. O., Ge, Y., Loo, J. A., Paša-Tolić, L., Tsybin, Y. O., Kelleher, N. L., & The Consortium for Top-Down Proteomics (2021) · Science Advances · doi:10.1126/sciadv.abk0734 · Cited by 242
Soh, J. H., Chan, H.-M., & Ying, J. Y. (2020) · Nano Today · doi:10.1016/j.nantod.2019.100831 · Cited by 230
Selection and Biosensor Application of Aptamers for Small Molecules
Pfeiffer, F., & Mayer, G. (2016) · Frontiers in Chemistry · doi:10.3389/fchem.2016.00025 · Cited by 224
“Furthermore, in the last couple of years, antibodies as the most widely used affinity tool have been questioned due to problems with variability between different batches and cross reactivity (Baker, 2015).”
BackgroundProtein Posttranslational Modifications: Roles in Aging and Age‐Related Disease
Santos, A. L., & Lindner, A. B. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/5716409 · Cited by 226
Schwenk, J. M., Omenn, G. S., Sun, Z., Campbell, D. S., Baker, M. S., Overall, C. M., Aebersold, R., Moritz, R. L., & Deutsch, E. W. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00467 · Cited by 230
“Recent discussions have indeed raised concerns about the reliability of affinity-based assays due to lack of reproducibility and specificity (59, 60).”
BackgroundSelf-citationGenomic evolution of cancer models: perils and opportunities
Ben-David, U., Beroukhim, R., & Golub, T. R. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-018-0095-3 · Cited by 222
Hardwicke, T. E., Wallach, J. D., Kidwell, M. C., Bendixen, T., Crüwell, S., & Ioannidis, J. P. A. (2020) · Royal Society Open Science · doi:10.1098/rsos.190806 · Cited by 217
Limitations of Animal Studies for Predicting Toxicity in Clinical Trials
Van Norman, G. A. (2020) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2020.03.010 · Cited by 186
“The lack of reproducibility in research using animal-based antibodies has been deemed a “crisis,” with some scientists claiming that over one-half of all commercially available antibodies are unreliable in binding their intended targets (32).”
BackgroundCuration of chemogenomics data
Fourches, D., Muratov, E., & Tropsha, A. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1881 · Cited by 192
Novel Strategies to Address the Challenges in Top-Down Proteomics
Melby, J. A., Roberts, D. S., Larson, E. J., Brown, K. A., Bayne, E. F., Jin, S., & Ge, Y. (2021) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.1c00099 · Cited by 190
Sanghavi, B. J., Moore, J. A., Chávez, J. L., Hagen, J. A., Kelley-Loughnane, N., Chou, C.-F., & Swami, N. S. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2015.11.044 · Cited by 191
Hardwicke, T. E., Thibault, R. T., Kosie, J. E., Wallach, J. D., Kidwell, M. C., & Ioannidis, J. P. A. (2022) · Perspectives on Psychological Science · doi:10.1177/1745691620979806 · Cited by 187
An Interactive Database for the Assessment of Histone Antibody Specificity
Rothbart, S. B., Dickson, B. M., Raab, J. R., Grzybowski, A. T., Krajewski, K., Guo, A. H., Shanle, E. K., Josefowicz, S. Z., Fuchs, S. M., Allis, C. D., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.06.022 · Cited by 178
“Consequently, poor antibody choice can lead to misinformed conclusions regarding the location and function of the histone PTM being queried (Baker, 2015).”
BackgroundCastillo, R. R., Colilla, M., & Vallet-Regí, M. (2017) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1211637 · Cited by 176
“8 Liposome Anti GD2 (sialoganglioside) NGR peptide (CD13, tumor vessel) DOX HTLA, SH-SY5Y and NXS2 (neuroblastoma) OVCAR-3 (ovarian) Colo-996N (lung) [116]”
Advancements in Aptamer Discovery Technologies
Gotrik, M. R., Feagin, T. A., Csordas, A. T., Nakamoto, M. A., & Soh, H. T. (2016) · Accounts of Chemical Research · doi:10.1021/acs.accounts.6b00283 · Cited by 177
Yüce, M., & Kurt, H. (2017) · RSC Adv. · doi:10.1039/c7ra10479k · Cited by 171
Aptamer-Based ELISA Assay for Highly Specific and Sensitive Detection of Zika NS1 Protein
Lee, K. H., & Zeng, H. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b02862 · Cited by 165
Platforms for Single-Cell Collection and Analysis
Valihrach, L., Androvic, P., & Kubista, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030807 · Cited by 164
Targeted cancer imaging and photothermal therapy via monosaccharide-imprinted gold nanorods
Yin, D., Li, X., Ma, Y., & Liu, Z. (2017) · Chemical Communications · doi:10.1039/c7cc02247f · Cited by 164
Effects of Rodent Thermoregulation on Animal Models in the Research Environment
Hankenson, F. C., Marx, J. O., Gordon, C. J., & David, J. M. (2018) · Comparative Medicine · doi:10.30802/aalas-cm-18-000049 · Cited by 159
Ali, G. K., & Omer, K. M. (2021) · Talanta · doi:10.1016/j.talanta.2021.122878 · Cited by 162
Tubulin or Not Tubulin: Heading Toward Total Protein Staining as Loading Control in Western Blots
Moritz, C. P. (2017) · PROTEOMICS · doi:10.1002/pmic.201600189 · Cited by 158
Leveraging big data to transform target selection and drug discovery
Chen, B., & Butte, A. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.318 · Cited by 160
“36 The misuse of antibodies may directly lead to the failure of experiments.”
BackgroundExtended gate field-effect-transistor for sensing cortisol stress hormone
Sheibani, S., Capua, L., Kamaei, S., Akbari, S. S. A., Zhang, J., Guerin, H., & Ionescu, A. M. (2021) · Communications Materials · doi:10.1038/s43246-020-00114-x · Cited by 158
Roberts, D. S., Loo, J. A., Tsybin, Y. O., Liu, X., Wu, S., Chamot-Rooke, J., Agar, J. N., Paša-Tolić, L., Smith, L. M., & Ge, Y. (2024) · Nature Reviews Methods Primers · doi:10.1038/s43586-024-00318-2 · Cited by 161
Top-down proteomics: challenges, innovations, and applications in basic and clinical research
Brown, K. A., Melby, J. A., Roberts, D. S., & Ge, Y. (2020) · Expert Review of Proteomics · doi:10.1080/14789450.2020.1855982 · Cited by 152
Schaefer, M., Kapoor, U., & Jantsch, M. F. (2017) · Open Biology · doi:10.1098/rsob.170077 · Cited by 172
Three-dimensional map of nonhematopoietic bone and bone-marrow cells and molecules
Coutu, D. L., Kokkaliaris, K. D., Kunz, L., & Schroeder, T. (2017) · Nature Biotechnology · doi:10.1038/nbt.4006 · Cited by 163
Review: Microbial analysis in dielectrophoretic microfluidic systems
Fernandez, R. E., Rohani, A., Farmehini, V., & Swami, N. S. (2017) · Analytica Chimica Acta · doi:10.1016/j.aca.2017.02.024 · Cited by 157
Overlooked Benefits of using Polyclonal Antibodies
Ascoli, C. A., & Aggeler, B. (2018) · BioTechniques · doi:10.2144/btn-2018-0065 · Cited by 142
Modern affinity reagents: Recombinant antibodies and aptamers
Groff, K., Brown, J., & Clippinger, A. J. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.10.004 · Cited by 146
“The routine complications associated with Western blotting—including nonspecific binding that results in either cross reactivity with similar proteins or a lack of detectable signal compared to noise—have been extensively reported (Baker, 2015; Bradbury and Plückthun, 2015).”
BackgroundInfluentialEngel, P., Boumsell, L., BALDERAS, R. S., Bensussan, A., Gattei, V., Hořejšı́, V., Jin, B., Malavasi, F., Mortari, F., Schwartz‐Albiez, R., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1502033 · Cited by 138
Mass spectrometry–based protein identification in proteomics—a review
Noor, Z., Ahn, S. B., Baker, M. S., Ranganathan, S., & Mohamedali, A. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbz163 · Cited by 148
Self-citationChristopher, J. A., Stadler, C., Martin, C. E., Morgenstern, M., Pan, Y., Betsinger, C. N., Rattray, D. G., Mahdessian, D., Gingras, A.-C., Warscheid, B., et al. (2021) · Nature Reviews Methods Primers · doi:10.1038/s43586-021-00029-y · Cited by 129
Pires, D. E. V., & Ascher, D. B. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw458 · Cited by 134
Wang, L., Balasubramanian, P., Chen, A. P., Kummar, S., Evrard, Y. A., & Kinders, R. J. (2016) · Seminars in Oncology · doi:10.1053/j.seminoncol.2016.06.004 · Cited by 134
Chang, Y.-F., Wang, W., Hong, Y.-W., Yuan, R.-Y., Chen, K.-H., Huang, Y.-W., Lu, P., Chen, Y., Chen, Y. A., Su, L., et al. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.7b03934 · Cited by 130
Irreproducibility in Preclinical Biomedical Research: Perceptions, Uncertainties, and Knowledge Gaps
Jarvis, M. F., & Williams, M. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.12.001 · Cited by 129
Rapid generation of potent antibodies by autonomous hypermutation in yeast
Wellner, A., McMahon, C., Gilman, M. S. A., Clements, J. R., Clark, S., Nguyen, K. M., Ho, M. H., Hu, V. J., Shin, J.-E., Feldman, J., et al. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00832-4 · Cited by 126
Marcon, E., Jain, H., Bhattacharya, A., Guo, H., Phanse, S., Pu, S., Byram, G., Collins, B. C., Dowdell, E., Fenner, M., et al. (2015) · Nature Methods · doi:10.1038/nmeth.3472 · Cited by 128
Shortened TDP43 isoforms upregulated by neuronal hyperactivity drive TDP43 pathology in ALS
Weskamp, K., Tank, E. M., Miguez, R., McBride, J. P., Gómez, N. B., White, M., Lin, Z., Gonzalez, C. M., Serio, A., Sreedharan, J., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci130988 · Cited by 126
Rosso, M., Wirz, R., Loretan, A. V., Sutter, N., da Cunha, C. T. P., Jarić, I., Würbel, H., & Voelkl, B. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104928 · Cited by 140
Xing, R., Wen, Y., Dong, Y., Wang, Y., Zhang, Q., & Liu, Z. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b01826 · Cited by 125
Generating Biologically Stable TNA Aptamers that Function with High Affinity and Thermal Stability
Dunn, M. R., McCloskey, C. M., Buckley, P. E., Rhea, K. A., & Chaput, J. C. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c00641 · Cited by 130
Proteomics tools reveal startlingly high amounts of oxytocin in plasma and serum
Brandtzaeg, O. K., Johnsen, E., Røberg‐Larsen, H., Seip, K. F., MacLean, E. L., Gesquiere, L. R., Leknes, S., Lundanes, E., & Wilson, S. R. (2016) · Scientific Reports · doi:10.1038/srep31693 · Cited by 128
Bauer, M., Strom, M., Hammond, D., & Shigdar, S. L. (2019) · Molecules · doi:10.3390/molecules24234377 · Cited by 131
“Furthermore, not all companies are immediately upfront in confirming the discontinuation of an antibody [2,19], which may leave long-term projects in limbo, resulting in further wastage of time and money.”
BackgroundResultInfluentialQuality Issues of Research Antibodies
Weller, M. G. (2016) · Analytical Chemistry Insights · doi:10.4137/aci.s31614 · Cited by 118
Never waste a good crisis: confronting reproducibility in translational research
Drucker, D. J. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.08.006 · Cited by 117
Examining the Roles of H3K4 Methylation States with Systematically Characterized Antibodies
Shah, R. N., Grzybowski, A. T., Cornett, E. M., Johnstone, A. L., Dickson, B. M., Boone, B. A., Cheek, M. A., Cowles, M. W., Maryanski, D. N., Meiners, M. J., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.08.015 · Cited by 127
Nelson, A. W., Groen, A. J., Miller, J. L., Warren, A. Y., Holmes, K. A., Tarulli, G. A., Tilley, W. D., Katzenellenbogen, B. S., Hawse, J. R., Gnanapragasam, V. J., et al. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.11.016 · Cited by 128
“Taken together, these findings reassert the importance of validating antibodies for individual experimental approaches, rather than assuming general applicability across methodological platforms (Baker, 2015; Bordeaux et al., 2010).”
BackgroundA perception-based nanosensor platform to detect cancer biomarkers
Yaari, Z. A., Yang, Y., Apfelbaum, E., Cupo, C., Settle, A. H., Cullen, Q., Cai, W., Roche, K. L., Levine, D. A., Fleisher, M., et al. (2021) · Science Advances · doi:10.1126/sciadv.abj0852 · Cited by 119
Tan, X., Constantin, T. P., Sloane, K. L., Waggoner, A. S., Bruchez, M. P., & Armitage, B. A. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b04211 · Cited by 114
Mesoporous Silica Nanoparticles as Carriers for Therapeutic Biomolecules
Castillo, R. R., Lozano, D., & Vallet‐Regí, M. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12050432 · Cited by 122
“This is of particular importance when preparing antibody-targeted nanosystems [34,35] and sensors.”
BackgroundA comparative analysis of cell surface targeting aptamers
Kelly, L., Maier, K. E., Yan, A. C., & Levy, M. (2021) · Nature Communications · doi:10.1038/s41467-021-26463-w · Cited by 114
Animal‐free alternatives and the antibody iceberg
Gray, A., Bradbury, A. R. M., Knappik, A., Plückthun, A., Borrebaeck, C. A. K., & Dübel, S. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0687-9 · Cited by 111
Li, W., Zhang, Q., Wang, Y., Ma, Y., Guo, Z., & Liu, Z. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b00465 · Cited by 112
An improved yeast surface display platform for the screening of nanobody immune libraries
Uchański, T., Zögg, T., Yin, J., Yuan, D., Wohlkönig, A., Fischer, B., Rosenbaum, D. M., Kobilka, B. K., Pardon, E., & Steyaert, J. (2019) · Scientific Reports · doi:10.1038/s41598-018-37212-3 · Cited by 114
From Whispering Gallery Mode Resonators to Biochemical Sensors
Loyez, M., Adolphson, M., Liao, J., & Yang, L. (2023) · ACS Sensors · doi:10.1021/acssensors.2c02876 · Cited by 111
Kong, M., Shin, J. H., Heu, S., Park, J., & Ryu, S. (2017) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2017.05.010 · Cited by 106
“Moreover, there is an increasing concern about the specificity, sensitivity, and stability of these antibodies (Baker, 2015).”
BackgroundBowen, A., & Casadevall, A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1504955112 · Cited by 104
“Common commercial products such as research antibodies suffer from batch-to-batch variability, uncharacterized cross-reactivity, and protocol-specific changes in binding specificity (29).”
BackgroundReproducibility2020: Progress and priorities
Freedman, L. P., Venugopalan, G., & Wisman, R. (2017) · F1000Research · doi:10.12688/f1000research.11334.1 · Cited by 102
Aptamer Conformational Change Enables Serotonin Biosensing with Nanopipettes
Nakatsuka, N., Faillétaz, A., Eggemann, D., Forró, C., Vörös, J., & Momotenko, D. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.0c05038 · Cited by 110
Enhanced validation of antibodies for research applications
Edfors, F., Hober, A., Linderbäck, K., Maddalo, G., Azimi, A., Sivertsson, Å., Tegel, H., Hober, S., Szigyarto, C. A.-K., Fagerberg, L., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06642-y · Cited by 104
Circumvention of common labelling artefacts using secondary nanobodies
Sograte-Idrissi, S., Schlichthaerle, T., Duque-Afonso, C. J., Alevra, M., Strauss, S., Moser, T., Jungmann, R., Rizzoli, S. O., & Opazo, F. (2020) · Nanoscale · doi:10.1039/d0nr00227e · Cited by 108
Mass spectrometric epitope mapping
Opuni, K. F. M., Al‐Majdoub, M., Yefremova, Y., El‐Kased, R. F., Koy, C., & Glocker, M. O. (2016) · Mass Spectrometry Reviews · doi:10.1002/mas.21516 · Cited by 102
Zhang, L., Wang, S., Yang, Z., Hoshika, S., Xie, S., Li, J., Chen, X., Wan, S., Li, L., Benner, S. A., et al. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201909691 · Cited by 95
Martinko, A. J., Truillet, C., Julien, O., Diaz, J. E., Horlbeck, M. A., Whiteley, G., Blonder, J., Weissman, J. S., Bandyopadhyay, S., Evans, M. J., et al. (2018) · eLife · doi:10.7554/elife.31098 · Cited by 91
“Moreover, others have shown that up to half of all commercially available antibodies are unreliable (Baker, 2015).”
BackgroundMuhammad, P., Tu, X., Liu, J. P., Wang, Y., & Liu, Z. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b00628 · Cited by 92
Simon, O., Yacoub, R., Jain, S., Tomaszewski, J. E., & Sarder, P. (2018) · Scientific Reports · doi:10.1038/s41598-018-20453-7 · Cited by 91
“Afield of machine learning, staining with antibodies to the intermediate filament nestin can highlight glomeruli [22], while in MRI, paramagnetic nanoparticles can outline the glomerular basement membrane [23]; however, such label-based methods are laborious and suffer from high variability and noise [24].”
BackgroundMicroRNA-302 switch to identify and eliminate undifferentiated human pluripotent stem cells
Parr, C., Katayama, S., Miki, K., Kuang, Y., Yoshida, Y., Morizane, A., Takahashi, J. B., Yamanaka, S., & Saito, H. (2016) · Scientific Reports · doi:10.1038/srep32532 · Cited by 96
The Rigor and Transparency Index Quality Metric for Assessing Biological and Medical Science Methods
Menke, J., Roelandse, M., Ozyurt, B., Martone, M., & Bandrowski, A. (2020) · iScience · doi:10.1016/j.isci.2020.101698 · Cited by 90
“Although there are many causes contributing to the complex issue of scientific irreproducibility within biological research, none have been more vilified than the antibody (Baker, 2015).”
BackgroundBCPT 2026 Policy for Experimental and Clinical Studies
Tveden‐Nyborg, P., Bergmann, T. K., Jessen, N., Simonsen, U., & Lykkesfeldt, J. (2025) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.70159 · Cited by 94
“The disclosure of an apparent and low degree of reproducibility has fuelled investigations of causal factors, ranging from behavioural preferences in decision-making/‘human nature’ and conviction bias to experimental constituents [2].”
The Antibody Registry: ten years of registering antibodies
Bandrowski, A., Pairish, M., Eckmann, P., Grethe, J., & Martone, M. E. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkac927 · Cited by 98
Immunohistochemistry in Investigative and Toxicologic Pathology
Janardhan, K. S., Jensen, H. L., Clayton, N. P., & Herbert, R. A. (2018) · Toxicologic Pathology · doi:10.1177/0192623318776907 · Cited by 88
“Since there is a huge market for antibodies, numerous companies have surfaced to offer a variety of antibodies for different applications (Baker 2015; Delpire 2015).”
InfluentialZhou, L., Wang, Y., Xing, R., Chen, J., Liu, J., Li, W., & Liu, Z. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.111729 · Cited by 87
Su, Y., Shi, Q., & Wei, W. (2017) · PROTEOMICS · doi:10.1002/pmic.201600267 · Cited by 99
“A recent publication raised serious concerns about the quality of the commercial antibodies [36,37].”
BackgroundA validated antibody panel for the characterization of tau post-translational modifications
Ercan, E., Eid, S., Weber, C., Kowalski, A., Bichmann, M., Behrendt, A., Matthes, F., Krauss, S., Reinhardt, P., Fulle, S., et al. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0229-1 · Cited by 87
“The most common problems with antibodies include cross-reactivity with nonspecific targets, variability from batch to batch and the use of wrong experimental systems [7].”
Chiron, C., Tompkins, T. A., & Burguière, P. (2018) · Journal of Applied Microbiology · doi:10.1111/jam.13666 · Cited by 84
“Besides, mAbs specificity is against a single epitope which can result in lower sensitivity or no binding at all if the target epitope is not accessible or in the correct conformation in native conditions (Baker 2015).”
Background
Metadata
- Authors
- Baker, M.
- Corresponding author
- Baker, Monya
- Venue
- Nature
- Published
- 2015-05-19
- Volume
- 521
- Issue
- 7552
- Pages
- 274-276
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1592986776
- Cited by
- 830
- References
- 7
- Citations by year
- 2026: 55 · 2025: 58 · 2024: 56 · 2023: 57 · 2022: 67 · 2021: 68 · 2020: 78 · 2019: 75 · 2018: 87 · 2017: 93 · 2016: 83 · 2015: 51
- Type
- other
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced Biosensing Techniques and Applications
- Keywords
- replication crisis, immunoglobulins, antibody validation, scientific rigor, research integrity
- MeSH terms
- Antibodies, Antibody Specificity, Cross Reactions, Humans, Indicators and Reagents, Membrane Proteins, Quality Control, Reagent Kits, Diagnostic, Reproducibility of Results, Artifacts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.